Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-06 2:55 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | STATE STREET CORP STT | 4,224,024 6.58% | 4,224,024 (New Position) | View |
| 2023-02-03 4:27 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 5,194,785 8.1% | 679,640 (+15.05%) | View |
| 2022-10-28 4:30 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,927,000 6.14% | 2,624,508 (+201.50%) | View |
| 2022-05-16 4:55 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 3,435,200 5.41% | 985,200 (+40.21%) | View |
| 2022-02-14 5:22 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | ARMISTICE CAPITAL LLC | 4,078,000 6.7% | 4,078,000 (New Position) | View |
| 2022-02-14 4:50 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | PERCEPTIVE ADVISORS LLC | 1,845,555 3% | -1,648,052 (-47.17%) | View |
| 2022-02-14 4:11 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 5,614,428 9.2% | 1,056,561 (+23.18%) | View |
| 2022-02-14 10:24 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 3,767,892 6.15% | 1,003,970 (+36.32%) | View |
| 2022-02-14 09:01 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 2,450,000 4% | -640,200 (-20.72%) | View |
| 2022-02-10 5:22 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | JANUS HENDERSON GROUP PLC JHG | 4,016,158 6.6% | -67,395 (-1.65%) | View |
| 2022-02-10 11:11 am Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,302,492 2.13% | -1,547,508 (-54.30%) | View |
| 2022-02-10 08:42 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | VANGUARD GROUP INC | 3,880,873 6.34% | 476,430 (+13.99%) | View |
| 2022-02-02 7:18 pm Sale | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 4,515,145 7.4% | -310,029 (-6.43%) | View |
| 2022-02-01 2:44 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | GOLDMAN SACHS GROUP INC GS | 4,599,279 7.5% | 4,599,279 (New Position) | View |
| 2021-08-13 4:27 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 3,090,200 5.09% | 3,090,200 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 4,557,867 8.9% | 4,557,867 (New Position) | View |
| 2021-02-16 3:30 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | PERCEPTIVE ADVISORS LLC | 3,493,607 6.8% | 3,493,607 (New Position) | View |
| 2021-02-16 2:40 pm Sale | 13G | RETROPHIN, INC. RTRX | Consonance Capital Management LP | 0 0% | -2,314,421 (Position Closed) | View |
| 2021-02-12 3:48 pm Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | JANUS HENDERSON GROUP PLC JHG | 4,083,553 8% | 4,083,553 (New Position) | View |
| 2021-02-12 08:41 am Purchase | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 2,763,922 5.41% | 2,763,922 (New Position) | View |